Astera Labs, INC Form 4 insider transactions

Astera Labs CEO Jitendra Mohan reported a gift of 150,000 shares of common stock to a non-affiliated entity.

Astera Labs' President and COO, Sanjay Gajendra, sold 91,441 shares of common stock to cover tax withholding obligations related to vested restricted stock units.

Astera Labs' General Counsel, Philip Mazzara, sold common stock on August 18, 2025, to cover tax withholding obligations from RSU vesting.

Astera Labs CEO Jitendra Mohan filed a Form 4 indicating a future non-discretionary sale of 91,441 shares of common stock on August 18, 2025, to cover tax withholding obligations.

Astera Labs' CFO, Michael Truett Tate, sold shares to cover tax obligations and transferred a significant block of shares to a family trust.

Astera Labs' CFO Michael Truett Tate amended a Form 4 filing to correct an administrative error regarding gifted shares and disclose significant stock sales and additional gifts.

Astera Labs Director Stefan A. Dyckerhoff reported gifting 11,000 shares of common stock at no cost, reducing his direct beneficial ownership.

Astera Labs' Chief Financial Officer, Michael Truett Tate, sold 99,000 shares of common stock for approximately $19.1 million through a pre-arranged 10b5-1 plan.

Astera Labs Director Stefan A. Dyckerhoff sold 52,000 shares of common stock over two days in August 2025, totaling approximately $9 million.

Astera Labs CEO Jitendra Mohan sold approximately $26 million worth of company common stock on August 7, 2025, through a pre-arranged Rule 10b5-1 trading plan.

Astera Labs CFO Michael Truett Tate sold approximately $17.1 million worth of company common stock and gifted additional shares in early August 2025, primarily through a pre-planned trading arrangement.

Astera Labs' President and COO, Sanjay Gajendra, sold 279,963 shares of common stock for approximately $47.3 million through a pre-arranged Rule 10b5-1 trading plan.

Astera Labs' Chief Financial Officer, Michael Truett Tate, was granted 43,238 restricted stock units under the company's 2024 Stock Option and Incentive Plan.

Astera Labs, Inc. General Counsel and Secretary Philip Mazzara was granted 16,214 restricted stock units, increasing his total beneficial ownership to 178,810 shares.

Astera Labs Director Manuel Alba sold 13,259 shares of common stock for $111 per share, executed automatically under a pre-arranged 10b5-1 trading plan.

Astera Labs' Chief Executive Officer, Jitendra Mohan, executed a pre-planned sale of 88,968 shares of common stock for approximately $10 million through a Rule 10b5-1 trading plan.

Astera Labs, Inc. CEO Jitendra Mohan sold a total of 126,258 shares of common stock on July 17 and July 18, 2025, through a pre-arranged Rule 10b5-1 trading plan.

Astera Labs' President and COO, Sanjay Gajendra, sold 165,000 shares of common stock on July 9, 2025, through pre-established Rule 10b5-1 trading plans.

Astera Labs, Inc. CEO Jitendra Mohan sold 18,264 shares of common stock across two days in July 2025, pursuant to a pre-arranged Rule 10b5-1 trading plan.

Astera Labs Director Manuel Alba has reported the sale of 92,991 shares of common stock across multiple transactions on July 2 and 3, 2025, executed under a Rule 10b5-1 trading plan.

Astera Labs Director Bethany Mayer reported the sale of 686 shares of common stock under a Rule 10b5-1 trading plan and the transfer of 839 shares to a family trust.

Astera Labs, Inc. CEO Jitendra Mohan has sold 52,743 shares of common stock for approximately $5.32 million through a pre-scheduled Rule 10b5-1 trading plan.

Astera Labs, Inc. Director and 10% Owner Manuel Alba reported the sale of 20,150 shares of common stock on June 20, 2025, executed automatically under a Rule 10b5-1 trading plan.

Astera Labs' President and COO, Sanjay Gajendra, sold 76,373 shares of common stock on June 18, 2025, through a pre-established Rule 10b5-1 trading plan.

Astera Labs, Inc. CEO Jitendra Mohan sold 106,510 shares of common stock for approximately $10.07 million on June 17, 2025, as part of a pre-established Rule 10b5-1 trading plan.

Astera Labs, Inc. Director Stefan A Dyckerhoff was granted 2,351 restricted stock units, vesting over the next year, as part of the company's 2024 Stock Option and Incentive Plan.

Astera Labs, Inc. Director Manuel Alba was granted 2,351 restricted stock units (RSUs) on June 8, 2025, as part of the company's 2024 Stock Option and Incentive Plan.

Astera Labs, Inc. Director Craig H. Barratt was granted 2,351 restricted stock units (RSUs) on June 8, 2025, aligning his interests with shareholders.

Astera Labs, Inc. Director Michael E. Hurlston was granted 2,351 restricted stock units (RSUs) on June 8, 2025, as part of the company's 2024 Stock Option and Incentive Plan.

Astera Labs, Inc. Director Jack R. Lazar was granted 2,351 restricted stock units (RSUs) on June 8, 2025, as part of the company's 2024 Stock Option and Incentive Plan.